The 1989 Lasker Award Affirms The Value Of Contraceptive Research

The Albert Lasker Clinical Medical Research Awards are certainly prestigious; indeed, they are widely regarded as comparable to the Nobel Prize. Since the Lasker awards were established in 1946, 48 winners have later been awarded Nobels, including J. Michael Bishop and Harold E. Varmus, University of California, San Francisco, who share this year’s prize in medicine for their breakthrough research on oncogenes. I take pride, incidentally, in our forecast of their recognition in the Octobe

Written byEugene Garfield
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The Albert Lasker Clinical Medical Research Awards are certainly prestigious; indeed, they are widely regarded as comparable to the Nobel Prize. Since the Lasker awards were established in 1946, 48 winners have later been awarded Nobels, including J. Michael Bishop and Harold E. Varmus, University of California, San Francisco, who share this year’s prize in medicine for their breakthrough research on oncogenes. I take pride, incidentally, in our forecast of their recognition in the October 2 issue of The Scientist (D. Pendlebury, “The 1989 Nobel Prize In Medicine: 20 Who Deserve It,” page 14).

The 1989 Lasker award was presented to Etienne-Emile Baulieu, University of Paris-Sud, for his research on steroid hormones, which has led to the development of RU486, an oral medication that terminates pregnancy.

By honoring Baulieu’s work, the Lasker jury has made a strong statement affirming the value of contraceptive research in general and RU486 in particular. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies